Clover Health Investments is trading lower Tuesday afternoon after the Trump administration proposed flat MA payment rates for 2027.

Over the last six months, Clover Health’s shares have sunk to $2.60, producing a disappointing 13.5% loss - a stark contrast ...

Clover Health Investments is now a contrarian buy, with the market underestimating its path to profitability in 2026. See why I rate the CLOV stock a Buy.

What Happened? Shares of health insurance company Clover Health (NASDAQ:CLOV) jumped 2.5% in the afternoon session after ...

Nashville, Tenn.-based insurance startup Clover Health is partnering with Nashville, Tenn.-based Thyme Care to collaborate on cancer care for underserved seniors. Announced Sept. 1, the partnership ...

Technology company Clover Health announced it will run its in-home primary care program, Clover Home Care, through CMS’ Direct Contracting Model. “The goal of Direct Contracting is to make the ...

WILMINGTON, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (CLOV) (“Clover,” “Clover Health” or the “Company”) today announced that Chelsea Clinton, the longest-serving ...

Clover Health Investments recently reported that its Medicare Advantage membership grew about 53% year over year to roughly ...

Clover Health Investments Corp (NASDAQ:CLOV) saw its shares jump more than 12.54% to $3.77 on Wednesday by market close, following better-than-expected profitability in the first quarter, despite ...

Clover delivers market-leading Medicare Advantage growth, establishing a strong path to achieve its first-ever full year GAAP Net Income profitability in 2026.Disciplined, core-market growth, strong ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Clover Health is betting its ...